At the XXIX Congress of the Czech Society of Internal Medicine ČLS JEP, held November 6−9, 2022 in Prague, lectures on innovative dyslipidemia therapy using the small interfering RNA molecule − inclisiran were presented at the Novartis company symposium.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
